These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 26784651)

  • 1. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
    Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
    Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).
    Bassuk SS; Manson JE; Lee IM; Cook NR; Christen WG; Bubes VY; Gordon DS; Copeland T; Friedenberg G; D'Agostino DM; Ridge CY; MacFadyen JG; Kalan K; Buring JE
    Contemp Clin Trials; 2016 Mar; 47():235-43. PubMed ID: 26767629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
    Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
    Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
    Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
    JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
    de Boer IH; Zelnick LR; Lin J; Schaumberg D; Wang L; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
    Contemp Clin Trials; 2018 Nov; 74():11-17. PubMed ID: 30282055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
    JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the Vitamin D and OmegA-3 trial (VITAL).
    Pradhan AD; Manson JE
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):252-6. PubMed ID: 25864623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Chasman DI; Lee IM; Bubes V; Li C; Haubourg M; Schaumberg DA;
    JAMA Ophthalmol; 2020 Dec; 138(12):1280-1289. PubMed ID: 33119047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.
    Okereke OI; Reynolds CF; Mischoulon D; Chang G; Cook NR; Copeland T; Friedenberg G; Buring JE; Manson JE
    Contemp Clin Trials; 2018 May; 68():133-145. PubMed ID: 29526608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial.
    Rafiq R; Prins HJ; Boersma WG; Daniels JM; den Heijer M; Lips P; de Jongh RT
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2583-2592. PubMed ID: 28894361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL).
    LeBoff MS; Yue AY; Copeland T; Cook NR; Buring JE; Manson JE
    Contemp Clin Trials; 2015 Mar; 41():259-68. PubMed ID: 25623291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial.
    Chandler PD; Chen WY; Ajala ON; Hazra A; Cook N; Bubes V; Lee IM; Giovannucci EL; Willett W; Buring JE; Manson JE;
    JAMA Netw Open; 2020 Nov; 3(11):e2025850. PubMed ID: 33206192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial.
    Limonte CP; Zelnick LR; Ruzinski J; Hoofnagle AN; Thadhani R; Melamed ML; Lee IM; Buring JE; Sesso HD; Manson JE; de Boer IH
    Diabetologia; 2021 Feb; 64(2):437-447. PubMed ID: 33098434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.
    Forno E; Bacharier LB; Phipatanakul W; Guilbert TW; Cabana MD; Ross K; Covar R; Gern JE; Rosser FJ; Blatter J; Durrani S; Han YY; Wisniewski SR; Celedón JC
    JAMA; 2020 Aug; 324(8):752-760. PubMed ID: 32840597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial.
    Orkaby AR; Dushkes R; Ward R; Djousse L; Buring JE; Lee IM; Cook NR; LeBoff MS; Okereke OI; Copeland T; Manson JE
    JAMA Netw Open; 2022 Sep; 5(9):e2231206. PubMed ID: 36098968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.
    Hahn J; Cook NR; Alexander EK; Friedman S; Walter J; Bubes V; Kotler G; Lee IM; Manson JE; Costenbader KH
    BMJ; 2022 Jan; 376():e066452. PubMed ID: 35082139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Lee IM; Bubes V; Friedenberg G; Dushkes R; Smith D; Schaumberg DA;
    JAMA Ophthalmol; 2022 Jul; 140(7):707-714. PubMed ID: 35679030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients.
    Su TC; Hwang JJ; Huang KC; Chiang FT; Chien KL; Wang KY; Charng MJ; Tsai WC; Lin LY; Vige R; Olivar JE; Tseng CD
    J Atheroscler Thromb; 2017 Mar; 24(3):275-289. PubMed ID: 27600795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vitamin D and omega-3 fatty acid supplementation on pain prevalence and severity in older adults: a large-scale ancillary study of the VITamin D and OmegA-3 triaL (VITAL).
    Soens MA; Sesso HD; Manson JE; Fields KG; Buring JE; Lee IM; Cook NR; Kim E; Bubes V; Dushkes R; Serhan CN; Rathmell JP
    Pain; 2024 Mar; 165(3):635-643. PubMed ID: 37878483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
    Martineau AR; James WY; Hooper RL; Barnes NC; Jolliffe DA; Greiller CL; Islam K; McLaughlin D; Bhowmik A; Timms PM; Rajakulasingam RK; Rowe M; Venton TR; Choudhury AB; Simcock DE; Wilks M; Degun A; Sadique Z; Monteiro WR; Corrigan CJ; Hawrylowicz CM; Griffiths CJ
    Lancet Respir Med; 2015 Feb; 3(2):120-130. PubMed ID: 25476069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.